Table 4. Characteristics of included longitudinal papers [n = 3, (43–45)] and conference abstracts [n = 3, (49–51)].

Author	Year	Country	N	Setting	Female (%)	Median Age, y	Response Rate	Follow-up (FU)	Assessor	Adherence, % threshold for measurement	Adherence Proportion (%)
Bonolo	2005	Brazil	306	Public referral hospital	35	35	73.4%	Median overall FU time: 247 days	patient	≥95%, number doses taken in past 3 days	cumulative: 36.9%
Erah	2008	Nigeria	102	HIV treatment centre	64	mean: 36.3 (7.9)	81.6	Unknown	patient	≥95%, number doses taken in past 30 d	58.1
Orrell	2003	South Africa	289	University HIV clinic	43	33.4 (8.7)	96.2	87.5% after 4 wk; 83.7% after 48 wk	pharmacy refill and pill count	≥90, medication dispensed minus pills returned/no. Pills prescribed over 48 weeks	63
Abstracts
Abah	2006	Nigeria	130	Teaching hospital	N/A	N/A	N/A	N/A	patient and pharmacy	≥95, % of doses prescribed over 6 month period	85.1
Darder	2004	South Africa	192	Clinic	N/A	N/A	N/A	N/A	patient	≥95, % of doses	88
Sidle	2007	Kenya	7381	clinics					patient	100	77
Summary (median, range)					43 (35–64)	35 (33.4–36.3)	81.6 (73–96.2)

N/A: Not Available.